• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MEF2-组蛋白去乙酰化酶轴在体外控制乳腺上皮细胞的增殖和腺泡形成。

The MEF2-HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro.

作者信息

Clocchiatti Andrea, Di Giorgio Eros, Viviani Giulia, Streuli Charles, Sgorbissa Andrea, Picco Raffaella, Cutano Valentina, Brancolini Claudio

机构信息

Dipartiment of Medical and Biological Sciences, Università degli Studi di Udine, P.le Kolbe 4, Udine 33100, Italy.

Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.

出版信息

J Cell Sci. 2015 Nov 1;128(21):3961-76. doi: 10.1242/jcs.170357. Epub 2015 Sep 24.

DOI:10.1242/jcs.170357
PMID:26403201
Abstract

The myocyte enhancer factor 2 and histone deacetylase (MEF2-HDAC) axis is a master regulator of different developmental programs and adaptive responses in adults. In this paper, we have investigated the contribution of the axis to the regulation of epithelial morphogenesis, using 3D organotypic cultures of MCF10A cells as a model. We have demonstrated that MEF2 transcriptional activity is upregulated during acini formation, which coincides with exit from the proliferative phase. Upregulation of the transcription of MEF2 proteins is coupled to downregulation of HDAC7, which occurs independently from changes in mRNA levels, and proteasome- or autophagy-mediated degradation. During acini formation, the MEF2-HDAC axis contributes to the promotion of cell cycle exit, through the engagement of the CDK inhibitor CDKN1A. Only in proliferating cells can HDAC7 bind to the first intron of the CDKN1A gene, a region characterized by epigenetic markers of active promoters and enhancers. In cells transformed by the oncogene HER2 (ERBB2), acini morphogenesis is altered, MEF2 transcription is repressed and HDAC7 is continuously expressed. Importantly, reactivation of MEF2 transcriptional activity in these cells, through the use of a HER2 inhibitor or by enhancing MEF2 function, corrected the proliferative defect and re-established normal acini morphogenesis.

摘要

肌细胞增强因子2与组蛋白去乙酰化酶(MEF2-HDAC)轴是成人不同发育程序和适应性反应的主要调节因子。在本文中,我们以MCF10A细胞的三维器官型培养为模型,研究了该轴在上皮形态发生调控中的作用。我们证明,在腺泡形成过程中MEF2转录活性上调,这与细胞从增殖期退出相吻合。MEF2蛋白转录的上调与HDAC7的下调相关联,HDAC7的下调独立于mRNA水平的变化以及蛋白酶体或自噬介导的降解。在腺泡形成过程中,MEF2-HDAC轴通过细胞周期蛋白依赖性激酶抑制剂CDKN1A的参与,促进细胞周期退出。只有在增殖细胞中,HDAC7才能与CDKN1A基因的第一个内含子结合,该区域具有活跃启动子和增强子的表观遗传标记。在由致癌基因HER2(ERBB2)转化的细胞中,腺泡形态发生改变,MEF2转录受到抑制,HDAC7持续表达。重要的是,通过使用HER2抑制剂或增强MEF2功能,在这些细胞中重新激活MEF2转录活性,纠正了增殖缺陷并重新建立了正常的腺泡形态发生。

相似文献

1
The MEF2-HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro.MEF2-组蛋白去乙酰化酶轴在体外控制乳腺上皮细胞的增殖和腺泡形成。
J Cell Sci. 2015 Nov 1;128(21):3961-76. doi: 10.1242/jcs.170357. Epub 2015 Sep 24.
2
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation.MEF2 是组蛋白去乙酰化酶 4 和磷脂酰肌醇 3-激酶/ Akt 诱导转化的汇聚枢纽。
Mol Cell Biol. 2013 Nov;33(22):4473-91. doi: 10.1128/MCB.01050-13. Epub 2013 Sep 16.
3
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.散发性和家族性肌萎缩侧索硬化症患者中MEF2D和MEF2C信号通路的破坏
Mol Cell Neurosci. 2016 Jul;74:10-7. doi: 10.1016/j.mcn.2016.02.002. Epub 2016 Feb 24.
4
Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.I 类和 IIa 类组蛋白去乙酰化酶在心房颤动进展中的相反作用。
J Mol Cell Cardiol. 2018 Dec;125:39-49. doi: 10.1016/j.yjmcc.2018.09.010. Epub 2018 Oct 12.
5
The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.细胞周期机制对MEF2稳定性的调控作用有助于CDKN1A的下调及进入S期。
Mol Cell Biol. 2015 May;35(9):1633-47. doi: 10.1128/MCB.01461-14. Epub 2015 Mar 2.
6
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.组蛋白去乙酰化酶3与肌细胞增强因子2相互作用并使其去乙酰化。
Mol Cell Biol. 2007 Feb;27(4):1280-95. doi: 10.1128/MCB.00882-06. Epub 2006 Dec 11.
7
Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation.I 类和 IIa 类组蛋白去乙酰化酶对骨硬化蛋白基因调控有相反的影响。
J Biol Chem. 2014 Sep 5;289(36):24995-5009. doi: 10.1074/jbc.M114.564997. Epub 2014 Jul 10.
8
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.尿路上皮癌中组蛋白去乙酰化酶(HDAC)表达模式的改变和 HDAC 抑制剂的活性。
Urol Oncol. 2013 Nov;31(8):1770-9. doi: 10.1016/j.urolonc.2012.06.015. Epub 2012 Sep 1.
9
Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA.当 IIa 类组蛋白去乙酰化酶衍生肽与与 DNA 结合的肌细胞增强因子 2 结合时,这些肽折叠成 α-螺旋。
J Mol Biol. 2024 May 1;436(9):168541. doi: 10.1016/j.jmb.2024.168541. Epub 2024 Mar 16.
10
The black sheep of class IIa: HDAC7 SIKens the heart.Ⅱa 类的害群之马:HDAC7 SIK 损伤心脏。
J Clin Invest. 2020 Jun 1;130(6):2811-2813. doi: 10.1172/JCI137074.

引用本文的文献

1
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.组蛋白去乙酰化酶驱动的抗癌耐药机制:表观遗传学及其他。
Cancer Drug Resist. 2024 Nov 20;7:46. doi: 10.20517/cdr.2024.103. eCollection 2024.
2
HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2.组蛋白去乙酰化酶7通过抑制肌细胞增强因子2来促进心肌细胞增殖。
J Mol Cell Biol. 2025 May 2;16(10). doi: 10.1093/jmcb/mjae044.
3
MEF2D Functions as a Tumor Suppressor in Breast Cancer.MEF2D 在乳腺癌中作为肿瘤抑制因子发挥作用。
Int J Mol Sci. 2024 May 10;25(10):5207. doi: 10.3390/ijms25105207.
4
Cell type and stage specific transcriptional, chromatin and cell-cell communication landscapes in the mammary gland.乳腺中细胞类型和阶段特异性的转录、染色质及细胞间通讯图谱。
Heliyon. 2023 Jun 30;9(7):e17842. doi: 10.1016/j.heliyon.2023.e17842. eCollection 2023 Jul.
5
A family with brachydactyly mental retardation syndrome with a missense variant in .一个患有短指智力发育迟缓综合征且存在错义变异的家族。 (注:原文中“in”后面缺少具体基因等相关内容,翻译根据已有完整信息尽量准确呈现)
Clin Pediatr Endocrinol. 2023;32(2):105-109. doi: 10.1297/cpe.2022-0076. Epub 2023 Feb 10.
6
HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications.癌症中的组蛋白去乙酰化酶4:一个不仅驱动表观遗传修饰的多任务平台。
Front Mol Biosci. 2023 Jan 24;10:1116660. doi: 10.3389/fmolb.2023.1116660. eCollection 2023.
7
HDAC5-mediated Smad7 silencing through MEF2A is critical for fibroblast activation and hypertrophic scar formation.HDAC5 通过 MEF2A 介导的 Smad7 沉默对于成纤维细胞活化和肥厚性瘢痕形成至关重要。
Int J Biol Sci. 2022 Sep 11;18(15):5724-5739. doi: 10.7150/ijbs.76140. eCollection 2022.
8
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks.多靶点武器:同时靶向VEGFR-2和HDAC癌症标志的二芳基吡唑啉噻唑烷二酮类化合物
RSC Med Chem. 2021 Jul 27;12(9):1540-1554. doi: 10.1039/d1md00125f. eCollection 2021 Sep 23.
9
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers.衰老过程中 HDAC4 的降解会在特定增强子和超级增强子上释放由 AP-1/p300 驱动的表观遗传程序。
Genome Biol. 2021 May 10;22(1):129. doi: 10.1186/s13059-021-02340-z.
10
VPS39-deficiency observed in type 2 diabetes impairs muscle stem cell differentiation via altered autophagy and epigenetics.在 2 型糖尿病中观察到的 VPS39 缺乏通过改变自噬和表观遗传学来损害肌肉干细胞分化。
Nat Commun. 2021 Apr 23;12(1):2431. doi: 10.1038/s41467-021-22068-5.